Ubs Group Ag Volitionrx LTD Transaction History

Ubs Group Ag

$397 Billion
Q1 2024

A detailed history of Ubs Group Ag transactions in Volitionrx LTD stock. As of the latest transaction made, Ubs Group Ag holds 28,458 shares of VNRX stock, worth $17,359. This represents 0.0% of its overall portfolio holdings.

Number of Shares

28,458

Previous 2,812 912.02%

Holding current value

$17,359

Previous $2,000 950.0%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.72 - $1.19 $18,465 - $30,518	25,646 Added 912.02%	28,458 $21,000
Q4 2023 Feb 09, 2024	BUY	$0.55 - $0.88 $514 - $823	936 Added 49.89%	2,812 $2,000
Q3 2023 Nov 09, 2023	SELL	$0.69 - $1.53 $6,231 - $13,817	-9,031 Reduced 82.8%	1,876 $1,000
Q2 2023 Aug 11, 2023	BUY	$1.39 - $2.02 $1,113 - $1,618	801 Added 7.93%	10,907 $15,000
Q1 2023 May 12, 2023	BUY	$1.54 - $2.68 $12,597 - $21,922	8,180 Added 424.71%	10,106 $19,000

Q4 2022 Feb 08, 2023	SELL	$1.63 - $2.6 $26,389 - $42,094	-16,190 Reduced 89.37%	1,926 $4,000
Q3 2022 Nov 10, 2022	BUY	$1.57 - $2.38 $23,294 - $35,312	14,837 Added 452.49%	18,116 $24,000
Q2 2022 Aug 10, 2022	SELL	$1.96 - $3.05 $5,039 - $7,841	-2,571 Reduced 43.95%	3,279 $7,000
Q1 2022 May 16, 2022	BUY	$2.41 - $3.24 $9,577 - $12,875	3,974 Added 211.83%	5,850 $18,000
Q3 2021 Nov 15, 2021	SELL	$2.98 - $3.48 $5,116 - $5,975	-1,717 Reduced 47.79%	1,876 $6,000
Q2 2021 Aug 13, 2021	SELL	$3.01 - $3.78 $18,023 - $22,634	-5,988 Reduced 62.5%	3,593 $11,000
Q1 2021 May 12, 2021	SELL	$3.33 - $6.5 $8,108 - $15,827	-2,435 Reduced 20.26%	9,581 $36,000
Q4 2020 Feb 11, 2021	BUY	$2.88 - $4.33 $20,534 - $30,872	7,130 Added 145.93%	12,016 $46,000
Q3 2020 Nov 12, 2020	SELL	$2.94 - $4.05 $24,848 - $34,230	-8,452 Reduced 63.37%	4,886 $15,000
Q2 2020 Jul 31, 2020	BUY	$2.89 - $4.32 $25,544 - $38,184	8,839 Added 196.47%	13,338 $51,000
Q1 2020 May 01, 2020	BUY	$2.47 - $5.16 $6,997 - $14,618	2,833 Added 170.05%	4,499 $14,000
Q4 2019 Feb 14, 2020	SELL	$4.28 - $5.95 $12,215 - $16,981	-2,854 Reduced 63.14%	1,666 $8,000
Q3 2019 Nov 14, 2019	BUY	$2.97 - $6.42 $5,978 - $12,923	2,013 Added 80.3%	4,520 $25,000
Q2 2019 Aug 14, 2019	BUY	$2.93 - $3.6 $2,464 - $3,027	841 Added 50.48%	2,507 $8,000
Q1 2019 May 14, 2019	SELL	$2.19 - $3.45 $3,725 - $5,868	-1,701 Reduced 50.52%	1,666 $5,000
Q4 2018 Feb 14, 2019	SELL	$1.7 - $2.88 $26,025 - $44,089	-15,309 Reduced 81.97%	3,367 $6,000
Q3 2018 Nov 14, 2018	BUY	$1.57 - $2.59 $26,181 - $43,190	16,676 Added 833.8%	18,676 $48,000
Q2 2018 Aug 14, 2018	SELL	$1.88 - $2.41 $5,617 - $7,201	-2,988 Reduced 59.9%	2,000 $4,000
Q1 2018 May 15, 2018	SELL	$2.29 - $3.95 $7,316 - $12,620	-3,195 Reduced 39.04%	4,988 $12,000
Q4 2017 Feb 14, 2018	BUY	$2.1 - $3.72 $11,606 - $20,560	5,527 Added 208.09%	8,183 $24,000
Q3 2017 Nov 14, 2017	SELL	$2.45 - $2.98 $6,536 - $7,950	-2,668 Reduced 50.11%	2,656 $7,000
Q2 2017 Aug 14, 2017	BUY	N/A	1,745 Added 48.76%	5,324 $19,000
Q1 2017 Nov 14, 2017	BUY	N/A	3,579	3,579 $14,000

Others Institutions Holding VNRX

# of Institutions

Shares Held

7.96M

Call Options Held

39K

Put Options Held

View Full List

About VOLITIONRX LTD

Ticker VNRX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 57,297,000
Market Cap $35M
Description
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...

More about VNRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account